HYPERTRIGLYCERIDEMIA
Clinical trials for HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame dangerous fat levels in blood
Disease control OngoingThis study tests a new medicine called RN0361 in healthy adults and people with very high triglycerides (a type of fat in the blood). The goal is to see if a single dose is safe and can lower fat levels. About 108 participants will receive either the drug or a placebo. The study …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1, PHASE2 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug aims to melt artery plaque in High-Risk patients
Disease control ENROLLING_BY_INVITATIONThis study tests an experimental drug, DR10624, to see if it can reduce fatty buildup (plaque) in the neck arteries of people with very high triglycerides. About 40 adults aged 18-65 will receive weekly injections of either the drug or a placebo for 24 weeks. The main goal is to …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: NA • Sponsor: Junbo Ge • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug Kylo-12 takes first step in human trials for high fat levels in blood
Disease control OngoingThis early-stage study tests a new medicine called Kylo-12 in about 50 healthy people with high triglycerides (a type of fat in the blood). The main goal is to check safety and how the body handles the drug. Researchers will also look at how it affects fat levels over time. This …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New shot every 3 months could tame dangerous blood fats
Disease control OngoingThis study tests a new medicine called plozasiran, given as an injection every 3 months, to lower high triglycerides (a type of blood fat) in adults. About 1,456 people will receive either the drug or a placebo for a year. The goal is to see if the drug safely reduces triglycerid…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New pill aims to tackle fatty liver, diabetes, and high cholesterol in one go
Disease control OngoingThis phase 2 study tests an experimental drug called MN-001 (tipelukast) in 40 adults with non-alcoholic fatty liver disease, type 2 diabetes, and high triglycerides. Participants take either the drug or a placebo daily for 24 weeks. The main goals are to see if the drug reduces …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug aims to slash stubborn fat in the blood
Disease control OngoingThis study tests an experimental drug called MAR001 in 216 adults with high triglycerides and remnant cholesterol, types of fat in the blood linked to heart disease. Participants receive either MAR001 or a placebo to see if the drug lowers these fats more than placebo. The goal i…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:38 UTC